ArticleBMC cancer2019

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET).

Carole Mercier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.